BPI-460372

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPI-460372, covering 2025-01-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BPI-460372 in Advanced Solid Tumor Patients [Phase 1]